# ADLARITY
> **NDA212304** · New Drug Application · Sponsor: CORIUM · Approved 2022-03-11
## Drug
- **FDA Application Number:** NDA212304
- **Application type:** New Drug Application
- **Brand name:** ADLARITY
- **Generic name:** Donepezil Hydrochloride
- **Active ingredients:** DONEPEZIL HYDROCHLORIDE
- **Dosage form:** SYSTEM
- **Route:** TRANSDERMAL
- **Marketing status:** Discontinued
- **Sponsor:** CORIUM
- **First approval:** 2022-03-11
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212304)
---
*MORVS · CC0 1.0*